Improve Sudden Cardiac Arrest Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 4222 participants.

Also called NCT02099721

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 4,222 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02099721
Other papers using this trial's data
  • Regional disparities and risk factors of mortality among patients at high risk of sudden cardiac death in emerging countries: a nonrandomized controlled trial BMC medicine, 2024-03-22 DOI, PubMed 38519982, PMC10960430 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Argentina, Belarus, Brazil, China, Colombia, Egypt, India, Malaysia, Mexico, Russia, Singapore, South Africa, South Korea, Taiwan, Tunisia, United Arab Emirates (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02099721. Non-randomized; no masking; primary purpose prevention. Start 2014-03 (actual); primary completion 2018-07-15 (actual). Results posted on 2020-10-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Improve Sudden Cardiac Arrest Study
Condition
Ventricular Arrythmia
Intervention (Device)
ICD or CRT-D Device
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct02099721
Content hash
1e20242808d7f482a962af3be88ee4d9f4d5bd9d3b436619c260f5d4e4f10403